Long-term angiotensin-converting enzyme inhibition with fosinopril improves depressed responsiveness to Ca2+ in myocytes from aortic-banded rats

Circulation

Volumn 94, Issue 11, 1996, Pages 2915-2922

  Kagaya, Yutaka ^c   Hajjar, Roger J ^c   Gwathmey, Judith K ^c   Barry, William H ^a   Lorell, Beverly H ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c NONE

Author keywords

calcium; heart failure; hypertrophy; myocytes; ventricles

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME INHIBITION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONTRACTILE FORCE; HEART VENTRICLE OVERLOAD; HEMODYNAMICS; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL;

EID: 0029848663     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.11.2915     Document Type: Article

References (48)

1. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Study Group. N Engl J Med. 1987;316:1429-1435.
2. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685-691.
3. Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L, Wedel H, on behalf of the CONSENSUS II Study Group. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med. 1992;327:678-684.
4. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker CC, Klein M, Wertheimer JH, Hawkins CM, on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Left Ventricular Enlargement Trial. N Engl J Med. 1992;327:669-677.
5. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985;57:84-95.
6. Nakashima Y, Fouad FM, Tarazi RC. Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol. 1984;53:1044-1049.
7. Dahlof B, Pennert K, Hansson L, Regression of left ventricular hypertrophy: a meta-analysis. Clin Exp Hypertens. 1992;A14:173-180.
8. Kromer EP, Elsner D, Riegger GAJ. Role of neurohormonal systems for pressure induced left ventricular hypertrophy in experimental supravalvular aortic stenosis in rats. Am J Hypertens. 1991;4:521-524.
9. Linz W, Schoelkens BA, Ganten D. Converting enzyme inhibitor specifically prevents development and induces the regression of cardiac hypertrophy in rats. Clin Exp Hypertens. 1989;11:1325-1350.
10. Weinberg EO, Schoen FJ, George D, Kagaya Y, Benedict CR, Lorell BH. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation. 1994;90:1410-1422.
11. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy: chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation. 1995;91:2642-2654.
12. Feldman A, Weinberg EO, Ray P, Lorell BH. Selective changes in gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 1993;73:184-192.
13. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility, and relaxation. J Clin Invest. 1990;86:1913-1920.
14. Schunkert H, Jackson B, Tang SS, Schoen FJ, Smits JFM, Apstein CS, Lorell BH. Distribution and functional significance of cardiac ACE in hypertrophied rat hearts. Circulation. 1993;87:1328-1339.
15. 2+- and species-dependent systolic and diastolic contractile properties of the intact muscle. J Gen Physiol. 1986;88:589-613.
16. Ca, and pH: studies in isolated beating hearts and myocytes loaded with the indicator indo 1. J Physiol (Lond). 1994;480:203-215.
17. Kagaya Y, Weinberg EO, Ito N, Mochizuki T, Barry WH, Lorell BH. Glycolytic inhibition: effects on diastolic relaxation and intracellular calcium handling in hypertrophied rat ventricular myocytes. J Clin Invest. 1995;95:2766-2776.
18. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
19. 2+ with indo-1 in feline myocytes. In: Clark W, ed. Biology of Isolated Adult Cardiac Myocytes. New York, NY: Elsevier Science Publishing Co; 1988:187-201.
20. i, to altered diastolic myocyte tone during partial metabolic inhibition. J Clin Invest. 1991;88:55-61.
21. Steadman BW, Moore KB, Spitzer KW, Bridge JHB. A video system for measuring motion in contracting heart cells. IEEE Trans Biomed Eng. 1988;35:264-272.
22. Cheung JY, Tillotson DL, Yelamarty RV, Scaduto RC Jr. Cytosolic free calcium concentration in individual cardiac myocytes in primary culture. Am J Physiol. 1989;256:C1120-C1130.
23. Borzak S, Kelly RA, Kramer BK, Matoba Y, Marsh JD, Reers M. In situ calibration of fura-2 and BCECF fluorescence in adult rat ventricular myocytes. Am J Physiol. 1990;259:H973-H981.
24. Arkhammer P, Nilsson T, Berggren PO. Glucose-stimulated efflux of indo-1 from pancreatic beta-cells is reduced by probenecid. FEBS Lett. 1990;273:182-184.
25. Tsutsui H, Tagawa H, Kent RL, McCollam PL, Ishihara K, Nagatsu M, Cooper G IV. Role of microtubules in contractile dysfunction of hypertrophied cardiocytes. Circulation. 1994;90:533-555.
26. Tsutsui H, Ishihara K, Cooper G. Cytoskeletal role in the contractile dysfunction of hypertrophied myocardium. Science. 1993;260:682-687.
27. Gwathmey JK, Hajjar RJ. Intracellular calcium related to force development in twitch contraction of mammalian myocardium. Cell Calcium. 1990;11:531-538.
28. 2+ regulation with resultant implications on contractile performance. J Mol Cell Cardiol. 1992;24:1459-1470.
29. 2+. Circulation. 1990;82:1266-1278.
30. Hajjar R, Gwathmey JK. Cross-bridge dynamics in human ventricular myocardium. Circulation. 1992;86:1819-1826.
31. Fabiato A, Fabiato F. Calculator programs for computing the compositions of solutions containing multiple metals and ligands used for experiments in skinned muscle cells. J Physiol Paris. 1979;75:463-505.
32. Gwathmey JK, Copelas L, MacKinnon R, Schoen F, Feldman M, Grossman W, Morgan JP. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circulation. 1987;75:331-339.
33. Boluyt MO, O'Neill L, Meredith AL, Bing OH, Brooks WN, Conrad CH, Crow MT, LaKatta EG. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure: marked upregulation of genes encoding extracellular matrix proteins. Circ Res. 1994;75:23-32.
34. Schwartz K, LeCarpentier Y, Martin JL, Lompre AM, Mercardier JJ, Swynghedauw B. Myosin isoenzymic distribution correlates with speed of myocardial contraction. J Mol Cell Cardiol. 1981;13:1071-1075.
35. 2+-ATPase gene in pressure overload induced cardiac hypertrophy in the rat. Circ Res. 1990;66:554-564.
36. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. Circ Res. 1993;72:463-469.
37. Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol. 1995;26:195-202.
38. Keung EC. Calcium current is increased in isolated adult myocyles from hypertrophied rat myocardium. Circ Res. 1989;64:753-763.
39. Litwin SE, Morgan JP. Captopril enhances intracellular calcium handling and β-adrenergic responsiveness of myocardium from rats with post-infarction failure. Circ Res. 1992;71:797-807.
40. Siri FM, Krueger J, Nordin C, Ming Z, Aronson RS. Depressed intracellular calcium transient and contraction in myocytes from hypertrophied and failing guinea pig hearts. Am J Physiol. 1991;261:H514-H530.
41. Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 1992;85:1046-1055.
42. 2+ sensitivity in intact versus skinned rat ventricular muscle. Circ Res. 1994;74:408-415.
43. 2+. Circulation. 1990;82:1266-1278.
44. Kentish JC, ter Keurs HE, Ricciardi L, Bucx JJ, Noble MI. Comparison between the sarcomere length-force relations of intact and skinned trabeculae from rat right ventricle: influence of calcium concentrations on these relations. Circ Res. 1986;58:755-768.
45. Gwathmey JK, Davidoff AJ. Experimental aspects of cardiomyopathy. Curr Opin Cardiol. 1993;8:480-495.
46. Anderson PAW, Malouf NN, Oakley A, Pagani ED, Allen PD. Troponin T isoform expression in humans: a comparison among normal and failing adult heart and adult and fetal skeletal muscle. Circ Res. 1991;69:1226-1233.
47. Margossian SS, White HD, Caulfield JB, Norton P, Taylor S, Slayter HS. Light chain-2 profile and activity of human ventricular myosin during dilated cardiomyopathy. Circulation. 1992;85:1720-1733.
48. 2+ sensitivity of tension at short sarcomere length. Circ Res. 1995;77:199-205.